Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 12 - 09 tags : Cancer save search
Immunic, Inc. Announces Enrollment of the First Patient in its Phase 1 Trial of IMU-935 in Metastatic Castration-Resistant Prostate Cancer
Published: 2021-12-09 (Crawled : 00:00) - biospace.com/
IMUX | $1.2 -5.51% -5.83% 360K
|
Health Technology
|
| O: 1.05%
H: 0.0%
C: 0.0%
imu-935 prostate cancer trial phase 1 cancer enroll
Spotlight Poster Presentation at San Antonio Breast Cancer Symposium SABCS 2021 Shows Oncocyte’s DetermaIO™ Clinical Test Predicts Response to Immunotherapy in Triple Negative Breast Cancer
Published: 2021-12-09 (Crawled : 00:00) - globenewswire.com
OCX | News J | $2.495 -2.54% -2.61% 50K
|
Health Technology
|
| O: -0.37%
H: 0.0%
C: 0.0%
symposium sabcs presentation immunotherapy test therapy cancer negative breast cancer
Context Therapeutics® Announces Positive Data from ONA-XR in Early Breast Cancer at 2021 San Antonio Breast Cancer Symposium
Published: 2021-12-09 (Crawled : 00:00) - globenewswire.com
CNTX | $1.39 -1.42% -1.44% 5.7K
|
Health Technology
|
| O: 18.21%
H: 3.38%
C: -27.3%
therapeutics symposium positive cancer breast cancer ona-xr
Ambrx Biopharma Inc. Presents Positive Data from Ongoing ACE-Breast-01 Phase 1 Clinical Study of ARX788 at San Antonio Breast Cancer Symposium
Published: 2021-12-09 (Crawled : 20:00) - biospace.com/
AMAM 4 | $28.0 0.0% 1.4M
|
Professional, Scientific, and T...
|
| O: 16.04%
H: 9.95%
C: -3.87%
arx788 biopharma ongoing symposium phase 1 positive cancer breast cancer
ENHERTU® Additional Analyses Further Reinforce Groundbreaking Efficacy in Patients with HER2 Positive Metastatic Breast Cancer
Published: 2021-12-09 (Crawled : 19:00) - biospace.com/
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.27%
H: 0.63%
C: -0.58%
enhertu positive cancer breast cancer her2- her2 metastatic breast cancer
BriaCell Summarizes Clinical Data Poster Presented at the 2021 San Antonio Breast Cancer Symposium®
Published: 2021-12-09 (Crawled : 17:00) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: 0.69%
H: 0.0%
C: 0.0%
symposium cancer breast cancer
Biocept’s CNSide Cerebrospinal Fluid Assay Identifies Actionable HER2 Mutations in Patients with Breast Cancer that has Metastasized to the Brain
Published: 2021-12-09 (Crawled : 14:30) - biospace.com/
BIOC | $0.4349 -10.32% 750K
|
Health Services
|
| O: -1.9%
H: 0.0%
C: 0.0%
cancer breast cancer her2- train her2
INmune Bio, Inc. Announces Key Breast Cancer Treatment Resistance Data to be Presented at the 2021 San Antonio Breast Cancer Symposium
Published: 2021-12-09 (Crawled : 14:30) - globenewswire.com
INMB | $8.33 -5.34% -5.64% 69K
|
Health Technology
|
| O: -0.88%
H: 2.56%
C: -0.08%
treatment cancer breast cancer symposium
PetDx Raises $62 Million in Series B Financing to Scale Adoption of its Canine Multi-Cancer Early Detection Blood Test, OncoK9
Published: 2021-12-09 (Crawled : 14:00) - prnewswire.com
WOOF F | $1.655 0.3% 0.3% 2.4M
|
|
| O: 1.82%
H: 1.32%
C: -2.7%
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: -3.94%
H: 1.79%
C: -1.34%
blood test cancer
Natera Presents Latest Signatera™ MRD Data in Breast Cancer at SABCS 2021
Published: 2021-12-09 (Crawled : 14:00) - prnewswire.com
NTRA S | $85.275 -2.3% -2.35% 2.5M
|
Health Services
|
| O: 2.38%
H: 0.94%
C: -4.95%
sabcs test cancer breast cancer
FDA Approves NGS-Based Companion Diagnostic for EGFR Exon20 Insertion Mutant Non-Small Cell Lung Cancer Tumor Tissue
Published: 2021-12-09 (Crawled : 14:00) - biospace.com/
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: 1.29%
H: 0.0%
C: 0.0%
diagnostic fda lung cancer cancer
Bionano Genomics Announces 2022 Symposium Featuring Four Consecutive Days of OGM Presentations and Live Panel Discussions Delivered by 25 Different Customers Across a Wide Range of Genetic Disease and Cancer Applications
Published: 2021-12-09 (Crawled : 13:30) - globenewswire.com
BNGO | $0.75 -4.73% -4.96% 980K
|
Health Technology
|
| O: 1.65%
H: 1.36%
C: -4.61%
genetic application genomics genomic liver presentation disease genetic disease cancer symposium
TYME Technologies, Inc. Announces Oral SM-88 Poster Accepted for Presentation at the 2022 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium
Published: 2021-12-09 (Crawled : 12:30) - biospace.com/
TYME | $0.3107 -8.21%
|
Health Technology
|
| O: 2.47%
H: 4.7%
C: -2.28%
sm-88 gastrointestinal presentation test cancer symposium
Exai Bio Secures $67.5 Million Series A Financing to Advance Next-Generation, RNA-Based Liquid Biopsy Platform for Early Cancer Detection
Published: 2021-12-09 (Crawled : 12:30) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.58%
H: 0.0%
C: 0.0%
cancer platform
Innate Pharma: Monalizumab Combined With Cetuximab and Durvalumab Demonstrates Anti-Tumor Activity in First-Line Recurrent or Metastatic Head and Neck Cancer at ESMO Immuno-Oncology 2021 Congress
Published: 2021-12-09 (Crawled : 11:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.09%
H: 0.32%
C: -0.26%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 0.2%
H: 1.6%
C: -2.8%
cancer
iOnctura Presents Positive Clinical Data At ESMO-IO Supporting Advancement of IOA-289, a Novel Autotaxin Inhibitor, Into Phase Ib Pancreatic Cancer Studies
Published: 2021-12-09 (Crawled : 08:00) - biospace.com/
PPRUF | $358.55 37.56% 1.5K
|
Consumer Non-Durables
|
| O: -6.26%
H: 4.62%
C: 0.72%
PPRUY | $36.0023 -0.11% 220K
|
Manufacturing
|
| O: -2.24%
H: 0.01%
C: -0.69%
ioa-289 xin positive cancer pancreatic
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.